Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 1 » Issue 1

Lower limb vasodilatory capacity is not reduced in patients with moderate COPD

Authors Surendran Sabapathy, Marc F Awater, Donald A Schneider, Rebecca A Kingsley, Maria TE Hopman, Norman R Morris

Published Date May 2006 Volume 2006:1(1) Pages 73—81

DOI

Published 4 May 2006

Surendran Sabapathy1, Marc F Awater2, Donald A Schneider1, Rebecca A Kingsley1, Maria TE Hopman2, Norman R Morris1

1School of Physiotherapy and Exercise Science, and Heart Foundation Research Centre, Gold Coast campus, Griffith University, QLD, Australia; 2Department of Physiology, University of Nijmegen, Nijmegen, The Netherlands

Abstract: We compared exercise capacity (peak O2 uptake; VO2peak) and lower limb vasodilatory capacity in 9 patients with moderate COPD (FEV1 52.7 ± 7.6% predicted) and 9 age-matched healthy control subjects.  VO2peak was measured via open circuit spirometry during incremental cycling. Calf blood flow (CBF) measurements were obtained at rest and after 5 minutes of ischemia using venous occlusion plethysmography. While VO2peak was significantly lower in the COPD patients (15.8 ± 3.5 mL·kg–1·min–1) compared with the control group (25.2 ± 3.5 mL·kg–1·min–1), there were no significant differences between groups in peak CBF or peak calf conductance measured 7 seconds post-ischemia. VO2peak was significantly correlated with peak CBF and peak conductance in the control group, whereas no significant relationship was found between these variables in the COPD group. However, the rate of decay in blood flow following ischemia was significantly slower (p < 0.05) for the COPD group (–0.036 ± 0.005 mL·100 mL–1·min–1·s–1) when compared with controls (–0.048 ± 0.015 mL·100mL–1·min–1·s–1). The results suggest that the lower peak exercise capacity in patients with moderate COPD is not related to a loss in leg vasodilatory capacity.

Keywords: obstructive lung disease, exercise capacity, reactive hyperemia, calf blood flow

Download Article [PDF] 

Readers of this article also read:

Mécano-Stimulation™ of the skin improves sagging score and induces beneficial functional modification of the fibroblasts: clinical, biological, and histological evaluations

Humbert P, Fanian F, Lihoreau T, Jeudy A, Elkhyat A, Robin S, Courderot-Masuyer C, Tauzin H, Lafforgue C, Haftek M

Clinical Interventions in Aging 2015, 10:387-403

Published Date: 2 February 2015

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy

Zhuang B, Li Z, Pang J, Li W, Huang P, Wang J, Zhou Y, Lin Q, Zhou Q, Ye X, Ye H, Liu Y, Zhang LM, Chen R

International Journal of Nanomedicine 2015, 10:939-947

Published Date: 29 January 2015

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups

Assaad-Khalil SH, Najem R, Sison J, Kitchlew AR, Cho BL, Ueng KC, DiTommaso S, Shete A

Vascular Health and Risk Management 2015, 11:71-78

Published Date: 21 January 2015

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies

Wang Z, Mu HJ, Zhang XM, Ma PK, Lian SN, Zhang FP, Chu SY, Zhang WW, Wang AP, Wang WY, Sun KX

International Journal of Nanomedicine 2015, 10:633-644

Published Date: 14 January 2015

Photothermal cancer therapy using graphitic carbon–coated magnetic particles prepared by one-pot synthesis

Lee HJ, Sanetuntikul J, Choi ES, Lee BR, Kim JH, Kim E, Shanmugam S

International Journal of Nanomedicine 2015, 10:271-282

Published Date: 30 December 2014

Glistenings in hydrophobic acrylic intraocular lenses do affect visual function

Beiko GHH, Grzybowski A

Clinical Ophthalmology 2013, 7:2271-2274

Published Date: 27 November 2013